Bisphosphonate use is associated with only a very low risk of atypical fractures to the subtrochanteric or diaphyseal femur, even in women who receive the drugs for up to 10 years, data from an ...

In addition, the continued use of bisphosphonates after 5 years is associated with an increased risk of otherwise rare subtrochanteric femoral fractures, osteonecrosis of the jaw, and esophageal ...